000 02309nam a22004097a 4500
008 220516s20222022 xxu||||| |||| 00| 0 eng d
022 _a0363-7913
040 _aOvid MEDLINE(R)
099 _a35211711
245 _aAdequacy Rate of Magnesium Citrate Bowel Preparation in a Large Retrospective Cohort.
251 _aRhode Island Medicine. 105(2):46-50, 2022 Mar 01.
252 _aR I Med. 105(2):46-50, 2022 Mar 01.
253 _aRhode Island medical journal (2013)
260 _c2022
260 _fFY2022
260 _p2022 Mar 01
265 _sepublish
266 _d2022-05-16
520 _aCONCLUSION: MC bowel preparation is adequate, well tolerated, and inexpensive. In a large retrospective analysis, it compares favorably to other preparations.
520 _aINTRODUCTION: Magnesium Citrate (MC) is not FDA approved as a colonoscopy preparation. Advantages include low cost, small volume and accessibility without prescription. We retrospectively evaluated bowel preparations used in a private gastroenterology practice. The sample size is the largest for any similar studies (n =19,173).
520 _aMETHODS: Electronic Medical Records were queried for colonoscopies between 2010-2016. Bowel preps, indications (screening vs. other) and preparation adequacy were all recorded. Adequacy rates were calculated and compared using generalized linear modeling. Data were analyzed using SAS.
520 _aRESULTS: The most common prep used was MC 2 bottles; screening (n=6,064, with 98.94% adequacy) and non-screening (n=3,251, with 99.29% adequacy), followed by MC 3 bottles; screening (n=2,757 with 90.35% adequacy), and non-screening (n=1,925 with 92.92% adequacy).
546 _aEnglish
650 _a*Cathartics
650 _a*Organometallic Compounds
650 _aCathartics/tu [Therapeutic Use]
650 _aCitric Acid/tu [Therapeutic Use]
650 _aHumans
650 _aOrganometallic Compounds/tu [Therapeutic Use]
650 _aRetrospective Studies
656 _aGastroenterology Fellowship
656 _aMedStar Georgetown University Hospital/MedStar Washington Hospital Center
657 _aJournal Article
700 _aAlSamman, Mohd Amer
790 _aAbeid M, AlSamman MA, Baird GL, Leung S, Moustafa A, Shah SA
942 _cART
_dArticle
999 _c545
_d545